FDA approves Aimmune's peanut allergy drug
January 31, 2020 at 17:12 PM EST
The U.S. Food and Drug Administration on Friday approved Aimmune Therapeutics Inc's drug to reduce, and potentially eliminate, allergic reactions to peanuts in children aged 4 to 17.
